Results 311 to 320 of about 1,270,000 (363)
Some of the next articles are maybe not open access.
Regimens for Cirrhotic Patients
Clinics in Liver Disease, 2015Therapy for hepatitis C has entered the era of all-oral direct-acting antiviral agents. Sustained response rates are now greater than 90% for all genotypes, although patients with cirrhosis remain the most difficult to treat. There are limited data for patients with cirrhosis and with hepatitis C genotypes 4 and 6 with cirrhosis.
openaire +3 more sources
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
The International Journal of Tuberculosis and Lung Disease, 2018A. Trébucq +17 more
semanticscholar +1 more source
Current treatment and future directions in the management of anal cancer
Ca-A Cancer Journal for Clinicians, 2022Leila T Tchelebi +2 more
exaly
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
Nature Reviews Clinical Oncology, 2021Roy S Herbst, Sarah B Goldberg
exaly
Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review
Journal of The American Geriatrics Society, 2017B. Wimmer +7 more
semanticscholar +1 more source
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021, Florian Castet, Mala K Maini
exaly
The International Journal of Tuberculosis and Lung Disease, 2018
A. Deun +5 more
semanticscholar +1 more source
A. Deun +5 more
semanticscholar +1 more source
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Nature Reviews Microbiology, 2022Véronique A Dartois, Eric J Rubin
exaly

